Rights and permissions
About this article
Cite this article
Intrathecal ziconotide for severe chronic pain: primary endpoint met. Inpharma Wkly. 1420, 6 (2004). https://doi.org/10.2165/00128413-200414200-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414200-00011